The consequences are more severe in susceptible individuals with reduced insulin sensitivity17 or glucose-stimulated insulin secretion18 before glucocorticoid treatment, as well as in obese females,19 first-degree relatives of type 2 diabetes patients20 and those at a higher age.21 The gene discussed is INS; the disease is type 2 diabetes mellitus.